Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference30 articles.
1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD 2017 Causes of Death Collaborators;Lancet,2018
2. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association;McClellan;Circulation,2019
3. Projections of Cardiovascular Disease Prevalence and Costs: 2015–2035;Khavjou,2016
4. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010;Smolina;Circ Cardiovasc Qual Outcomes,2012
5. Reprint of: Impact of lipids on cardiovascular health: JACC Health Promotion Series;Ference;J Am Coll Cardiol,2018
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and effectiveness of interference RNA (RNAi) based therapeutics in cardiac failure: A systematic review;Heart & Lung;2024-11
2. Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database;International Journal of Clinical Pharmacy;2024-08-27
3. Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis;Expert Opinion on Drug Discovery;2024-05-28
4. Broader Perspective on Atherosclerosis—Selected Risk Factors, Biomarkers, and Therapeutic Approach;International Journal of Molecular Sciences;2024-05-10
5. Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran;Journal of the American Heart Association;2024-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3